Filing Details
- Accession Number:
- 0001640334-21-000147
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-20 16:56:45
- Reporting Period:
- 2021-01-14
- Accepted Time:
- 2021-01-20 16:56:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
895464 | Yubo International Biotech Ltd | YBGJ | Electromedical & Electrotherapeutic Apparatus (3845) | 113074326 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1828515 | Lina Liu | Yubo International Biotech Limited Room 105, Building 5, Xishiku Avenue Xicheng District, Beijing F4 00000 | Cfo, Treasurer And Secretary | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Disposition | 2021-01-14 | 116,697,438 | $0.00 | 0 | No | 4 | D | Direct | |
Class A Common Stock | Acquisiton | 2021-01-14 | 13,829,400 | $0.00 | 13,829,400 | No | 4 | P | Indirect | By Focus Draw Group |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | D | Direct | |
No | 4 | P | Indirect | By Focus Draw Group |
Footnotes
- The shares reported herein were surrendered to the issuer and canceled in connection with an exchange transaction by and among Platinum International Biotech Co., Ltd.("Platinum"),Yubo International Biotech (Beijing) Limited, the Reporting Person and certain other stockholders of Platinum. No cash consideration was paid in connection with surrender and cancellation of the shares.
- The shares reported herein were acquired in connection with an exchange transaction by and among Platinum International Biotech Co., Ltd. ("Platinum"), Yubo International Biotech (Beijing) Limited, the Reporting Person and certain other stockholders of Platinum. The Issuer issued the shares reported herein to the Reporting Person in exchange for the Reporting Person's equity interest in Platinum. No cash consideration was paid in connection with the exchange transaction.
- The shares are held by Focus Draw Group, of which the reporting person is the sole director. The Reporting Person disclaims beneficial ownership of the securities except to the extent of her pecuniary interest therein.